{
  "ptid_time": "127_S_0754_2008-10-03",
  "img_path": "/data/qiuhui/data/adni/images/127_S_0754/2008-10-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 82,781 mm³, 270.6% above the reference mean. With a Z-score of 6.77 (100.0th percentile), this represents profound enlargement; whole brain volume measures 1,034,410 mm³, 0.5% above the reference mean. With a Z-score of 0.06 (52.5th percentile), this represents normal volume . ",
  "text_data": "Age is 69.7 years. Gender is Female. Education: 14 years. MMSE: 20.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Pittsburgh compound B: 1.90 SUVR (normal ); Amyloid beta: 344.00 pg/mL (moderate reduced); Total tau: 281.60 pg/mL (normal ); Phosphorylated tau: 27.24 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows profound ventricular enlargement (Z-score 6.77), suggesting significant brain atrophy, alongside a borderline-low MMSE (20/30) and moderately reduced Aβ, which is consistent with Alzheimer's pathology. However, tau markers (T-tau, P-tau) are normal, which may indicate early-stage disease or a mixed etiology.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **Medium** (due to conflicting tau biomarkers and lack of detailed cognitive history)",
  "timestamp": "2025-07-26T13:03:07.378797"
}